Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 04:02 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | AR | 80 beds | Grade C | EBITDA uplift $2.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 043029 | CRAIGHEAD, AR | 80 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 80-bed suburban community hospital in CRAIGHEAD, AR with $36.3M in net patient revenue and a 27.9% operating margin. The hospital serves a payer mix of 60.4% Medicare, 11.2% Medicaid, and 28.5% commercial.

Thesis: Turnaround. Our ML models identify $2.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 27.9% to 35.3% (+736bps).

Net Revenue HCRIS$36.3M
Current EBITDA COMPUTED$10.1M
Operating Margin COMPUTED27.9%
Occupancy HCRIS91.3%
Revenue / Bed COMPUTED$454K
Net-to-Gross HCRIS56.9%
Distress Probability ML45.8%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
35
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 27.9% places it above the state median. Among 35 size-comparable peers (40-160 beds), the median margin is -1.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)AR80$36.3M27.9%
ARKANSAS HEART HOSPITALAR112$205.9M1.2%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%
BHMC-CONWAYAR108$94.7M-15.6%
ST. MARYS REGIONAL MEDICAL CENAR137$94.3M6.7%
SALINE MEMORIAL HOSPITALAR130$91.4M-8.0%
NORTH ARKANSAS REGIONAL MEDICAAR120$89.1M-13.9%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$762K+210bp18mo
Cost to Collect4.5%2.5%$726K+200bp12mo
Denial Rate Reduction12.0%6.5%$719K+198bp12mo
A/R Days Reduction5200.0%3800.0%$442K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$762K
Cost to Collect
$726K
Denial Rate Reduction
$719K
A/R Days Reduction
$442K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.7M
Current EBITDA$10.1M
+ RCM Uplift+$2.7M
Pro Forma EBITDA$12.8M
Current Margin27.9%
Pro Forma Margin35.3%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$15.6M$93.6M6.00x43.1%
Base (11x exit)10.0x11.0x$15.6M$108.0M6.93x47.3%
Bull Case9.0x11.0x$14.0M$121.9M8.69x54.1%
Bull (12x exit)9.0x12.0x$14.0M$137.1M9.77x57.8%
Bear Case11.0x10.0x$17.1M$75.1M4.38x34.4%
Bear (11x exit)11.0x11.0x$17.1M$88.2M5.14x38.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 60.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 40-160 beds
  • Same-state prioritization (n=36)
  • Comp margins: P25=-15.7% / P50=-1.1% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.